
HRMY
Harmony Biosciences Holdings Inc.
$36.89
-$1.08(-2.84%)
69
Overall
80
Value
72
Tech
55
Quality
Market Cap
$2.14B
Volume
474.51K
52W Range
$26.47 - $41.61
Target Price
$50.45
Order:
Income Statement
Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|
REVENUE | |||||||
Total Revenue | $159.7M | $305.4M | $437.9M | $582.0M | $714.7M | ||
Total Revenue | $159.7M | $305.4M | $437.9M | $582.0M | $714.7M | ||
COST OF GOODS SOLD | |||||||
Cost of Revenue | $27.7M | $55.5M | $83.5M | $121.2M | $156.8M | ||
GROSS PROFIT | |||||||
Gross Profit | $132.0M | $249.9M | $354.4M | $460.8M | $557.9M | ||
OPERATING EXPENSES | |||||||
Operating Expenses | $115.0M | $162.4M | $234.2M | $268.8M | $367.1M | ||
Research & Development | $19.4M | $30.4M | $70.9M | $76.1M | $145.8M | ||
Research Expense | $19.4M | $30.4M | $70.9M | $76.1M | $145.8M | ||
Selling, General & Administrative | $95.6M | $132.0M | $163.3M | $192.7M | $221.3M | ||
Selling & Marketing Expenses | $55.8M | $68.1M | $79.3M | $97.4M | $110.9M | ||
General & Administrative Expenses | $39.7M | $63.9M | $84.0M | $95.3M | $110.4M | ||
Promotion & Advertising | $13.3M | $19.6M | $22.4M | $21.5M | $27.6M | ||
Salaries & Wages | $4.7M | $15.7M | $26.9M | $31.2M | $42.7M | ||
Amortization | $164.8M | $146.2M | $162.6M | $140.4M | $114.0M | ||
Other Operating Expenses | $686.0K | $1.2M | $1.5M | $1.8M | $2.1M | ||
OPERATING INCOME | |||||||
Operating income | $17.0M | $87.5M | $120.2M | $192.0M | $190.8M | ||
EBITDA | $1.5M | $80.5M | $123.5M | $223.8M | $234.1M | ||
NON-OPERATING ITEMS | |||||||
Interest Expense (Non-Operating) | $28.2M | $24.2M | $18.8M | $23.8M | $17.5M | ||
Intinc | $-28.2M | $-24.0M | $-15.7M | -- | -- | ||
Net Non-Operating Interest Income/Expense | $-28.2M | $-24.0M | $15.7M | $-23.8M | $-17.5M | ||
Gain on Sale of Securities | -- | -- | $3.1M | $14.7M | $18.5M | ||
Other Income/Expense | $25.7M | $26.1M | $169.0K | $-5.1M | $-18.5M | ||
Other Special Charges | $-25.7M | $-26.1M | $169.0K | $-9.6M | $-68.0K | ||
PRE-TAX INCOME | |||||||
EBIT | $-8.7M | $61.6M | $123.5M | $197.2M | $209.3M | ||
Pre-Tax Income | $-36.9M | $37.4M | $104.7M | $173.4M | $191.8M | ||
INCOME TAX | |||||||
Tax Provision | $-6.4M | $2.8M | $-76.8M | $44.5M | $46.3M | ||
NET INCOME | |||||||
Net Income | $-36.9M | $34.6M | $181.5M | $128.9M | $145.5M | ||
Net Income (Continuing Operations) | $-36.9M | $34.6M | $181.5M | $128.9M | $145.5M | ||
Net Income (Discontinued Operations) | $-36.9M | $34.6M | $181.5M | $128.9M | $145.5M | ||
Net Income (Common Stockholders) | $-63.8M | $34.6M | $181.5M | $128.9M | $145.5M | ||
Normalized Income | -- | -- | -- | -- | $189.9M | ||
TOTALS | |||||||
Total Expenses | $142.8M | $217.9M | $317.7M | $390.0M | $523.9M | ||
SHARE & EPS DATA | |||||||
Average Shares Outstanding | $25.8M | $57.5M | $59.2M | $59.5M | $56.9M | ||
Average Shares Outstanding (Diluted) | $25.8M | $59.2M | $61.1M | $60.4M | $57.9M | ||
Shares Outstanding | $56.9M | $58.9M | $59.6M | $56.8M | $57.3M | ||
Basic EPS | $-2.48 | $0.60 | $3.07 | $2.17 | $2.56 | ||
Basic EPS (Continuing Operations) | $-2.48 | $0.60 | $3.07 | $2.17 | $2.56 | ||
Diluted EPS | $-2.48 | $0.58 | $2.97 | $2.13 | $2.51 | ||
Diluted EPS (Continuing Operations) | $-2.48 | $0.58 | $2.97 | $2.13 | $2.51 | ||
OTHER METRICS | |||||||
Accrued Preferred Stock Dividends | $26.9M | -- | -- | -- | -- | ||
Interest Expense Operating | $26.2M | $22.0M | -- | -- | -- | ||
Other Gand A | $39.7M | $63.9M | $84.0M | $95.3M | $110.4M | ||
Otherunder Preferred Stock Dividend | $26.9M | -- | -- | -- | -- | ||
Preferred Stock Dividends | $26.9M | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | HRMY | $36.89 | -2.8% | 474.51K |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Harmony Biosciences Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW